Four-year retrospective study of autoimmune
hemolytic anemia in children in the Czech Republic
Jabali Y.1, Zdráhalová K.2, Starý J.2, Bláhová K.3, Klodová D.4, Černá Z.5, Hrstková H.6, Novák Z.7, Procházková D.8, Toušovská K.9, Písačka M.10 za pracovní skupinu pro dětskou hematologii v České republice
1Dětská klinika, Nemocnice, České Budějovice, 2II. dětská klinika 2. LF UK a FN Motol, Praha, 3I. dětská klinika 2. LF UK a FN Motol, Praha, 4Klinika dětského lékařství FNsP, Ostrava, 5Klinika chorob dětských FNsP, Plzeň, 6Dětská interní klinika, Brno, 7Dětská klinika FNsP, Olomouc, 8Dětská klinika IPVZ a Masarykovy nemocnice, Ústí nad Labem, 9Dětská klinika FN, Hradec Králové, 10Ústav hematologie a krevní transfuse, Praha |
|
Summary:
Autoimmune hemolytic anemia is a rare disease in childhood. Its course is variable and unpredictable.
The optimal management particularly of the chronic form of the illness is not well defined. A retrospective
study of cases occurring in children, excluding newborns, in the Czech Republic from 1998 to 2001
has been undertaken using a structured questionnaire. The aim of the study was to survey the state of
diagnostics and management of this disease as well as to look for pertinent prognostic factors.
Autoimmune hemolytic anemia was diagnosed in 32 children aged from 1.2 to 18.8 years (median: 7.6).
There were 18 boys and 14 girls in this series (M:F = 1.3:1). Twenty-three patients had an acute form
and 8 a chronic form of the disease. In 22 cases, the disease was idiopathic (primary) and in 10, it was
secondary with an associated chronic disorder involving the immune system. The acute form was very
often associated with a recent or concomitant infection, usually of viral origin, and affected mainly
young children (median age: 4.6 years), with slightly more boys being afflicted (M:F = 1.3:1). By contrast,
the chronic form was encountered rather in older children (median age: 12.6 years), equally affecting
both sexes, and was more frequently associated with a chronic underlying disease (6/8 vs 4/23) and
relatively more often presented as Evans’ syndrome (3/8 vs 3/23). Warm-reacting, cold-reacting, mixed
and bithermal antibodies were found in 12, 9, 4 and 2 patients, respectively, and data on thermal
optimum and amplitude were not available in 5 cases. One patient was not treated for the anemia, 31
received steroids, 8 additional therapy (of these, 4 were given immunosuppressive drugs), and 12
required transfusion. None underwent splenectomy. While all children with the acute form recovered,
7/8 with the chronic form have been living with evidence of disease.
Key words:
autoimmune hemolytic anemia, Evans’ syndrome, children, retrospective study
|